Clinical Trial: Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07026149) titled 'Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer' on June 10.

Brief Summary: The study is being conducted to evaluate the efficacy, safety and tolerability of radiotherapy and chemotherapy, apatinib with camrelizumab in the neoadjuvant (prior to surgery) and adjuvant (after surgery) treatment of previously untreated adults with gastric and gastroesophageal junction (GEJ) adenocarcinoma.

Study Start Date: June 08

Study Type: INTERVENTIONAL

Condition: Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

Intervention: DRUG: Apatinib+Camrelizumab+SOX

Apatinib 2...